07/30/2025
3:53 PM | Adams Brian (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2025
3:54 PM | Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2025
3:54 PM | Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2025
3:54 PM | Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
3:12 PM | Relay Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2025
3:15 PM | Mazumdar Claire (Reporting)
Relay Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/06/2025
4:50 PM | Relay Therapeutics (Issuer)
Rubin Jami (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
4:51 PM | Murcko Mark (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
4:51 PM | Kathiresan Sekar (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
4:51 PM | INGRAM DOUGLAS S (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
4:52 PM | Borisy Alexis (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for RLAY and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Relay Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
06/06/2025
4:52 PM | HILL LINDA A (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
3:15 PM | Relay Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/30/2025
7:23 PM | Adams Brian (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2025
7:24 PM | Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2025
7:24 PM | Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2025
7:25 PM | Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2025
3:10 PM | Relay Therapeutics (Filer)
| Form DEFA14A | |
04/23/2025
3:15 PM | Relay Therapeutics (Filer)
| Form ARS | |
04/23/2025
3:05 PM | Relay Therapeutics (Filer)
| Form DEF 14A | |
03/20/2025
5:13 PM | Point72 Asset Management, L.P. (Filed by)
Relay Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/26/2025
3:10 PM | Relay Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2025
7:56 PM | Patel Sanjiv (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
12:23 PM | BlackRock, Inc. (Filed by)
Relay Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/30/2025
8:02 PM | Adams Brian (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
8:06 PM | Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
8:10 PM | Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
8:16 PM | Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
6:01 PM | Patel Sanjiv (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
3:03 PM | Patel Sanjiv (Reporting)
Relay Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025
3:04 PM | Patel Sanjiv (Reporting)
Relay Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/14/2025
8:00 PM | Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
8:00 PM | Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
8:00 PM | Patel Sanjiv (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
8:00 PM | Adams Brian (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
8:00 PM | Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
7:30 AM | Relay Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/06/2025
7:35 PM | Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:05 PM | Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:05 PM | Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:05 PM | Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
FOUR TRILLION DOLLARS! (Ad) Nvidia just became the first company in history to hit a $4 trillion valuation—surpassing Apple and Microsoft. But one controversial analyst, known for predicting the collapses of Fannie Mae, GM, and others, is issuing a serious warning.
He believes Nvidia’s rise has masked a dangerous flaw—and that the stock could fall 50% or more from current levels. Click here to watch his urgent Nvidia exposé before the hype turns to panic. |
12/31/2024
3:05 PM | Adams Brian (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2024
3:01 PM | Catinazzo Thomas (Reporting)
Relay Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
3:18 PM | Patel Sanjiv (Reporting)
Relay Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2024
6:00 AM | Relay Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
3:10 PM | Relay Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
3:07 PM | Adams Brian (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
3:08 PM | Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
3:09 PM | Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
3:09 PM | Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2024
3:05 PM | Catinazzo Thomas (Reporting)
Relay Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024
3:45 PM | Relay Therapeutics (Filer)
| Form 424B5 | |
09/11/2024
3:49 PM | Relay Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
3:43 PM | Relay Therapeutics (Filer)
| Form 424B5 | |
09/09/2024
7:00 AM | Relay Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
